Thirona has successfully renewed its ISO 13485 and EU MDR certifications and, for the first time, achieved certification under the Medical Device Single Audit Program (MDSAP).

We are proud to announce the expansion of our Medical Advisory Board with the addition of three world-renowned pulmonologists

To achieve our mission of advancing personalized and tailored approaches to lung disease treatment and care, we are welcoming top clinical experts to Thirona's Medical Advisory Board.

MedTech companies Aidence, Incepto, and Thirona jointly introduce a comprehensive AI-powered software package for lung cancer screening and the analysis of emphysema

Following the second 2023 EIC Accelerator cut-off in March, Thirona is awarded to receive European Innovation Council (EIC) funding.

2 abstracts of major importance for advancing the treatment of pulmonary vascular diseases, and pulmonary hypertension in particular, were presented today at ATS 2023 International Conference in Washington by Julien Guiot from CHU de Liège.